We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$2.25B
AUM Growth
+$68.7M
Cap. Flow
+$47.8M
Cap. Flow %
2.12%
Top 10 Hldgs %
19.72%
Holding
2,202
New
81
Increased
603
Reduced
556
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 8.69%
2 Financials 4.6%
3 Healthcare 4.02%
4 Consumer Discretionary 3.1%
5 Industrials 2.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMUS icon
1026
T-Mobile US
TMUS
$186B
$57.3K ﹤0.01%
325
+30
+10% +$5.03K
DCI icon
1027
Donaldson
DCI
$11.3B
$57.2K ﹤0.01%
800
ZBH icon
1028
Zimmer Biomet
ZBH
$19B
$57.2K ﹤0.01%
527
HSIC icon
1029
Henry Schein
HSIC
$10.2B
$57.2K ﹤0.01%
892
UAUG icon
1030
Innovator US Equity Ultra Buffer ETF August
UAUG
$164M
$56.9K ﹤0.01%
1,690
NLR icon
1031
VanEck Uranium + Nuclear Energy ETF
NLR
$4.04B
$56.8K ﹤0.01%
710
+554
+355% +$45.2K
DFAX icon
1032
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.3B
$56.7K ﹤0.01%
2,232
-6,914
-76% -$177K
DFAI
1033
Dimensional International Core Equity Market ETF
DFAI
$17.8B
$56.4K ﹤0.01%
+1,900
New +$57K
FFC
1034
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$778M
$56.4K ﹤0.01%
3,810
-165
-4% -$2.38K
RNR icon
1035
RenaissanceRe
RNR
$13.4B
$55.9K ﹤0.01%
250
-6
-2% -$1.34K
FMAR icon
1036
FT Vest US Equity Buffer ETF March
FMAR
$1.15B
$54.9K ﹤0.01%
1,354
ELAN icon
1037
Elanco Animal Health
ELAN
$13.1B
$54.9K ﹤0.01%
3,807
-530
-12% -$8.47K
SRTY icon
1038
ProShares UltraPro Short Russell2000
SRTY
$73M
$54.9K ﹤0.01%
+494
New +$56.5K
NECB icon
1039
Northeast Community Bancorp
NECB
$374M
$54.5K ﹤0.01%
3,060
BLES icon
1040
Inspire Global Hope ETF
BLES
$164M
$54.4K ﹤0.01%
1,489
+74
+5% +$2.73K
COKE icon
1041
Coca-Cola Consolidated
COKE
$12.3B
$54.3K ﹤0.01%
500
-100
-17% -$9.26K
BIIB icon
1042
Biogen
BIIB
$30.5B
$54.2K ﹤0.01%
234
-7
-3% -$1.52K
SPGI icon
1043
S&P Global
SPGI
$121B
$54.2K ﹤0.01%
121
-5
-4% -$2.15K
AXON
1044
Axon Enterprise
AXON
$49.1B
$53.8K ﹤0.01%
183
OVV icon
1045
Ovintiv
OVV
$16B
$53.6K ﹤0.01%
1,144
+282
+33% +$14.2K
JEMA icon
1046
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.67B
$53.5K ﹤0.01%
1,400
+514
+58% +$19.2K
DWX icon
1047
State Street SPDR S&P International Dividend ETF
DWX
$527M
$53.3K ﹤0.01%
1,548
-1,126
-42% -$39.3K
ISMD icon
1048
Inspire Small/Mid Cap Impact ETF
ISMD
$344M
$53.2K ﹤0.01%
1,535
+79
+5% +$2.74K
IHE icon
1049
iShares US Pharmaceuticals ETF
IHE
$1.64B
$52.9K ﹤0.01%
798
WTV icon
1050
WisdomTree US Value Fund
WTV
$3.36B
$52.9K ﹤0.01%
725
-75
-9% -$5.49K

Similar funds

Geneos Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, Geneos Wealth Management held 2,202 positions worth $2.25B, up 3.1% from $2.18B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneos Wealth Management's Q2 2024 filing shows 81 new, 603 increased, 556 reduced and 149 closed positions. Its largest new stake was Dimensional International Core Equity 2 ETF: 225,058 shares worth $5.92M. The largest sale was iShares Core S&P Small-Cap ETF, an estimated $16M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.

  • Geneos Wealth Management's largest Q2 2024 buy was Dimensional International Core Equity 2 ETF: 225,058 shares worth $5.92M.
  • Geneos Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $28.5M increase.
  • Geneos Wealth Management's biggest Q2 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $16M.
  • Geneos Wealth Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.03M.
  • Geneos Wealth Management's ten largest holdings make up 20% of its $2.25B portfolio in Q2 2024.
  • Geneos Wealth Management opened 81 new positions and closed 149 in Q2 2024.
  • Geneos Wealth Management's portfolio value rose 3.1% quarter-over-quarter to $2.25B.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.